Farms.com Home   News

Sclerotinia risk high this year

Canola fields are starting to bloom.

Justine Cornelsen is Agronomic and Regulatory Services Manager with BrettYoung.

"It's obviously been a slow start to the spring but things are progressing," she said. "We still do have a bulk of acres that are sitting around that four to six leaf stage getting ready to bulk. I imagine in the next week here, we're really going to see things start to turn yellow. We've had some high humidity and some heat and a lot of rain so there's going to be a fairly large risk for sclerotinia this year."

She notes most of the crop is past the flea beetle stage.

"Earlier this spring lots were being sprayed because of the intense pressure. Mainly due to the crop just having a really slow growth. That crop kind of sat there for a few weeks and didn't really move and that's where the flea beetles really took over. That should be in the past now and we're moving forward."

Cornelsen says there have been a lot of hail claims this year, with a severe storm passing through the Dauphin and Interlake regions a few weeks ago. She notes canola at an early stage is able to bounce back from hail damage fairly well.

"When you start losing pods and blooms and flowers, that's where you start to see a little bit more of a yield penalty on those crops," she added.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.